Le Lézard
Classified in: Science and technology

NASA Astronaut to Inspire Artemis Generation in Boston


WASHINGTON, April 22, 2024 /PRNewswire/ -- NASA astronaut Stephen Bowen, along with representatives from NASA and the International Space Station National Laboratory, will visit Boston on Wednesday, April 24, and Thursday, April 25, as part of the agency's Destination Station to highlight research opportunities aboard the station.

Destination Station was created to educate the public and engage prospective researchers about the benefits, capabilities, and opportunities to use the space station. The space station has been continuously inhabited for more than 23 years, enabling more than 5,000 researchers to conduct more than 3,500 innovative experiments in the areas of biology and biotechnology, human health, space and physical science, and technology.

Throughout the week, NASA and the ISS National Lab will meet with a variety of academic institutions, business incubators, and private-sector companies with ties to the Boston community. During the visits, Bowen will provide perspectives on living and working in space.

Media who wish interview Bowen during the outreach events in Boston, should contact Kara Slaughter at [email protected] or 281-483-5111.

Bowen was the first submarine officer selected to be a NASA astronaut. He most recently served as commander of NASA's SpaceX Crew-6 mission to the station where he was part of a six-month research mission, Expedition 69. He is a veteran of three space shuttle flights to the station, including STS-126, STS-132, and STS-133. Bowen has logged a total of 227 days in space and conducted 10 extravehicular activities in his career. His 10 spacewalks make him one of five humans who have conducted that many spacewalks and he is third on the all-time list for most cumulative spacewalking time. Bowen and the crews of Expedition 68 and 69 conducted more than 200 science experiments including tissue chip research, bioprinting human cells and tissues in space, and studying antibodies in microgravity. Bowen is a Massachusetts native and earned his bachelor's degree from the United States Naval Academy in Annapolis, Maryland, and his master's degree from the Massachusetts Institute of Technology in Cambridge.

Over the years, NASA's Destination Station has led to research collaborations aboard the orbiting laboratory with a variety of academic and commercial companies. This visit also is a prelude to the 13th annual International Space Station Research and Development Conference at the Boston Marriott Copley Square from July 29 ? Aug. 1, 2024.

Learn more about the International Space Station and its crews at:

http://www.nasa.gov/station

Discover the International Space Station U.S. National Laboratory at:

https://www.issnationallab.org

 

SOURCE NASA


These press releases may also interest you

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl...



News published on and distributed by: